Bell will provide review of progress...NOTE All illustrations and photos have been removed from this article.

Steve Bell, vice president of research and preclinical development for BioSante, will present review of progress with BioVantTM, the companys patented calcium phosphate CaP nanoparticle technology, at the Second International Conference on Immunopotentiators in Modern Vaccines. Article, News, Research, Information, Industry & Business News View article excerpt Read this article Try Goliath Business News FREE!You can view this article PLUS... Bell will provide review of progress...NOTE All illustrations and photos have been removed from this article. Business News Whether it be strategic planning, sales prospecting, company research or defining management best practices Goliath is your leading source for accurate information.

330 Dr. Business News Steve Bell, vice president of research and preclinical development for BioSante, will present review of progress with BioVantTM, the companys patented calcium phosphate CaP nanoparticle technology, at the Second International Conference on Immunopotentiators in Modern Vaccines IMV 2005 meeting in Malaga, Spain. Browse by Publication Browse or Search over million articles Find Articles by Publication Home Bell will provide review of progress...NOTE All illustrations and photos have been removed from this article. Dr. ET. 330 ET. More articles from Business WirePublic Relations Blog, Online Publicity Journal, Announces Site Redesign with Additional Press Release Resources.

Dr. 330 Industry Information The presentation entitled, Calcium Phosphate Nanoparticles versus Microparticles Selective Th1 versus Th2 Immunity, will take place at More articles from Business WirePublic Relations Blog, Online Publicity Journal, Announces Site Redesign with Additional Press Release Resources., 15JAN08SYNNEX Corporation Sets Record and Meeting Dates for Annual Meeting of Stockholders., 11JAN08Arrow Electronics to Acquire Components Distribution Business of Hynetic Electronics and Shreyanics Electronics in India., 11JAN08Looking for additional articles? Click here to search our complete database of Industry & Market reports by text, subject, publication name or publication date.

Steve Bell, vice president of research and preclinical development for BioSante, will present review of progress with BioVantTM, the companys patented calcium phosphate CaP nanoparticle technology, at the Second International Conference on Immunopotentiators in Modern Vaccines IMV 2005 meeting in Malaga, Spain. Business News Bell will provide review of progress...